Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02434341
Other study ID # s-20140207G
Secondary ID
Status Completed
Phase N/A
First received April 30, 2015
Last updated April 27, 2016
Start date May 2015
Est. completion date April 2016

Study information

Verified date April 2016
Source University of Southern Denmark
Contact n/a
Is FDA regulated No
Health authority Denmark: Ethics Committee
Study type Observational

Clinical Trial Summary

15 patients with sepsis, 15 patients with COPD and 15 surgical patients will undergo polysomnographic sleep monitoring up to 24 hours in order to define if there are common sleep features within the groups


Description:

It is an observational study in order to define if there are common polysomnographic sleep features within the following three groups of wake critically ill patients on mechanical ventilation in ICU: the group of septical patients, the group of patients with chronic obstructive pulmonary disease in exacerbation and the group of surgical patients without sepsis.

15 patients will be included in each group. They will undergo polysomnographic sleep monitoring during up to 24 hours.

Polysomnograms will be studies then in order to find out if there are common sleep characteristics within the homogeneous patient groups of critically ill.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date April 2016
Est. primary completion date April 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- wake non-sedated patients

- mechanical ventilation

Exclusion Criteria:

- age < 18 years

- pregnant

- Glasgow Coma Scale < 11

- sedated patients

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Polysomnographic Sleep Characteristics

Locations

Country Name City State
Denmark Intensive Care Unit, Odense University Hospital Odense

Sponsors (1)

Lead Sponsor Collaborator
University of Southern Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary polysomnographic sleep features polysomnographic sleep assessment during up to 24 hours No